Reliance Pharma Fund Unrated

Value Research
Change from previous, NAV as on Apr 29, 2016
Category: Equity: Pharma
Assets: R 1,408 crore (As on Mar 31, 2016)
Expense: 2.16% (As on Mar 31, 2016)
Investment Objective

The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.

Fund Managers
+ Sailesh Raj Bhan since Mar 2005
comments powered by Disqus